This website uses cookies
Read our Privacy policy and Terms of use for more information.
Sep 14, 2026
Mint launches fully in Q1 2027, and its new 3D Intelligence algorithm gives clinicians three dosing options to better fit each patient's needs.
The Eversense 365 implantable continuous glucose monitor will expand support to a second insulin pump before the end of the year.
May 29, 2026
A deep dive at the pros and cons of bi-hormonal pumps, how they work, and the two currently in-development by Beta Bionics and Inreda.
May 26, 2026
The timeline reflects recent FDA feedback and manufacturing progress, with pharmacy access, CGM compatibility, and no recharging required at launch.
Mar 31, 2026
A new reporting feature for the iLet Bionic Pancreas helps clinicians quickly identify what’s working and where diabetes management can be improved.
Feb 4, 2026
The warning letter highlights quality system and reporting concerns, but isn't expected to impact the iLet insulin pump production or distribution.
Nov 17, 2025
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
Aug 29, 2025
The tubeless pump dubbed "Mint" promises to make changing infusion sets more simple without the use of a phone.
Aug 26, 2025
The future of insulin delivery is tubeless, screenless, phoneless—and even movement-tracking. Here are the devices in development you need to know about.
